David W. Fry
David W. Fry publishes mostly in Molecular Biology, Oncology and Organic Chemistry, on topics such as HER2/EGFR in Cancer Research, Quinazolinone synthesis and applications and Synthesis and biological activity.
- World rank
- #337,165 of 7,710,434 ranked researchers
- Rank in New Zealand
- #1,246 of 21,128
- Works
- 176
- Citations
- 11k
- Citations per work
- 59.8
What does David W. Fry research?
David W. Fry's work is mostly in Medicine (32%), Biochemistry, Genetics and Molecular Biology (23%), Chemistry (21%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5732.3%
- Medicine5732.3%
- Everything else4324.2%
- Life Sciences4022.8%
- Physical Sciences3620.7%
- Chemistry3620.7%
- 1Molecular Biology23% of their works
- 2Oncology21% of their works
- 3Organic Chemistry21% of their works
- 4Pulmonary and Respiratory Medicine6% of their works
- 5Radiology, Nuclear Medicine and Imaging4% of their works
- 6Epidemiology2% of their works
Research topics
- HER2/EGFR in Cancer Research
- Quinazolinone synthesis and applications
- Synthesis and biological activity
- Cancer therapeutics and mechanisms
- Synthesis and Characterization of Heterocyclic Compounds
- Lung Cancer Treatments and Mutations
- Biochemical and Molecular Research
- Monoclonal and Polyclonal Antibodies Research
Which keywords describe David W. Fry's research?
The keywords of their largest research topics: Chemotherapy, Antimicrobial, Synthesis, Breast Cancer, HER2, Indirubin, Quinazoline and Heterocyclic Compounds.
- Fc Receptors
- Enzyme Regulation
- EGFR Mutations
- Drug Discovery
- DNA
- Heterocyclic Compounds
- Indirubin
- Breast Cancer
- Antimicrobial
- Chemotherapy
- Synthesis
- HER2
- Quinazoline
- Medicinal Chemistry
- Topoisomerases
- Triazines
- Targeted Therapy
- Nucleotide Metabolism
- Therapeutic Antibodies
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Chemotherapy642 topics
- Antimicrobial452 topics
- Synthesis452 topics
- Breast Cancer441 topic
- HER2441 topic
- Indirubin261 topic
- Quinazoline261 topic
- Heterocyclic Compounds231 topic
- Medicinal Chemistry231 topic
- DNA201 topic
- Topoisomerases201 topic
- Drug Discovery191 topic
- Triazines191 topic
- EGFR Mutations171 topic
- Targeted Therapy171 topic
- Enzyme Regulation161 topic
- Nucleotide Metabolism161 topic
- Fc Receptors151 topic
- Therapeutic Antibodies151 topic
Where does David W. Fry work?
David W. Fry's main affiliation in the publication record is University of Auckland, New Zealand.
How many publications and citations does David W. Fry have?
OpenAlex counts 176 works and 10,532 citations for David W. Fry, an h-index of 49, ranking #337,165 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David W. Fry. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.